BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29350487)

  • 1. Pediatric patients with cutaneous melanoma: A European study.
    Brecht IB; De Paoli A; Bisogno G; Orbach D; Schneider DT; Leiter U; Offenmueller S; Cecchetto G; Godzinski J; Bien E; Stachowicz-Stencel T; Ben-Ami T; Chiaravalli S; Maurichi A; De Salvo GL; Sorbara S; Bodemer C; Garbe C; Reguerre Y; Ferrari A
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26974. PubMed ID: 29350487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study.
    Ipenburg NA; Lo SN; Vilain RE; Holtkamp LHJ; Wilmott JS; Nieweg OE; Thompson JF; Scolyer RA
    J Am Acad Dermatol; 2020 Apr; 82(4):910-919. PubMed ID: 31682859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric and Adolescent Melanoma: A National Cancer Data Base Update.
    Lorimer PD; White RL; Walsh K; Han Y; Kirks RC; Symanowski J; Forster MR; Sarantou T; Salo JC; Hill JS
    Ann Surg Oncol; 2016 Nov; 23(12):4058-4066. PubMed ID: 27364504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous melanoma in children and adolescents: the Italian rare tumors in pediatric age project experience.
    Ferrari A; Bisogno G; Cecchetto G; Santinami M; Maurichi A; Bono A; Vajna De Pava M; Pierani P; Bertolini P; Rossi CR; De Salvo GL
    J Pediatr; 2014 Feb; 164(2):376-82.e1-2. PubMed ID: 24252782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP).
    Offenmueller S; Leiter U; Bernbeck B; Garbe C; Eigentler T; Borkhardt A; Classen CF; Corbacioglu S; Dirksen U; Ebetsberger-Dachs G; Heinzerling L; Jorch N; Kuhlen M; Lawlor J; Niggli F; Streiter M; Schneider DT; Brecht I
    Klin Padiatr; 2017 Nov; 229(6):322-328. PubMed ID: 29017184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
    Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
    Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
    Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
    Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose adjuvant interferon for stage III malignant melanoma.
    Inman JL; Russell GB; Savage P; Levine EA
    Am Surg; 2003 Feb; 69(2):127-30. PubMed ID: 12641352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution.
    Ferrari A; Bono A; Baldi M; Collini P; Casanova M; Pennacchioli E; Terenziani M; Marcon I; Santinami M; Bartoli C
    Pediatrics; 2005 Mar; 115(3):649-54. PubMed ID: 15741367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous melanoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations.
    Ferrari A; Lopez Almaraz R; Reguerre Y; Cesen M; Bergamaschi L; Indini A; Schneider DT; Godzinski J; Bien E; Stachowicz-Stencel T; Eigentler TK; Chiaravalli S; Krawczyk MA; Pappo A; Orbach D; Bisogno G; Brecht IB
    Pediatr Blood Cancer; 2021 Jun; 68 Suppl 4():e28992. PubMed ID: 34174159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp.
    Cappello ZJ; Augenstein AC; Potts KL; McMasters KM; Bumpous JM
    Laryngoscope; 2013 Jun; 123(6):1411-5. PubMed ID: 23625541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma: Kids are not just little people.
    LaChance A; Shahriari M; Kerr PE; Grant-Kels JM
    Clin Dermatol; 2016; 34(6):742-748. PubMed ID: 27968934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
    Ghaferi AA; Wong SL; Johnson TM; Lowe L; Chang AE; Cimmino VM; Bradford CR; Rees RS; Sabel MS
    Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma in children and the use of sentinel lymph node biopsy.
    Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
    J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.